TrialClinical drug investigation2011

Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.

Domenic Sica et al.PubMed ↗Publisher ↗

No numbers read from the abstract.